|
NeoGenomics
https://neogenomics.com/ About NeoGenomics
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland and Singapore. NeoGenomics has been serving the cancer community for over 17 years, and each member of our team is committed to our mission: Save lives by improving patient care. |
Representatives will be available for meetings from
2 p.m. to 3 p.m. on June 12. |
